RapidPulse closes oversubscribed $48 million Series B round co-led by Medtronic, S3 Ventures

  • SHVMS LLC portfolio company RapidPulse closed an oversubscribed USD 48 million Series B to fund clinical development of its stroke aspiration thrombectomy system.
  • Round co-led by Medtronic, TechWald Next, S3 Ventures; syndicate included SBI Investment, Florida Opportunity Fund, Santé Ventures.
  • Proceeds to complete the TURBO IDE study in the US and Europe; support a planned FDA approval filing, subject to results.
  • Funding also backs expansion of RapidPulse’s pulsed aspiration platform, including a broader catheter size lineup.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SHVMS LLC published the original content used to generate this news brief on July 16, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.